Oryzon to present at upcoming international conferences
MADRID, SPAIN and CAMBRIDGE MA.
• 13th Annual International Partnering Conference BIO-Europe Spring VIENNA
• 14th International Conference on Alzheimer's and Parkinson's Diseases (ADPD2019) LISBON
Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the company will continue its institutional presence in several reputed international conferences in the upcoming weeks.
Click here to see the full Press Release